Royal Philips and Masimo have renewed their multi-year strategic collaboration, deepening their long-standing partnership to accelerate the delivery of next-generation patient monitoring solutions. The expanded agreement underscores both companies’ commitment to innovation, interoperability, and improved clinical outcomes across the continuum of care.
Partnership Highlights
- Integration of Masimo technologies:
- SET® pulse oximetry
- Radius PPG®
- A portfolio of advanced sensor technologies - Embedded into Philips’ multi-parameter monitoring platforms including:
- Bedside monitors
- Central stations
- Wearable solutions
This unified ecosystem gives clinicians reliable, actionable insights and the flexibility to use their preferred measurement technologies within a single system.
Next-Generation Monitoring Development
Beyond integration, Philips and Masimo will:
- Co-develop and co-promote new monitoring solutions addressing emerging needs such as:
- Greater patient mobility
- Advanced wearables
- AI-driven algorithms for predictive insights - Focus on smart, connected care that scales with evolving clinical and operational demands.
Leadership Perspectives
- Julia Strandberg, EVP & Business Leader, Connected Care at Philips:
“This partnership allows us to respond quickly to evolving clinical needs and market trends, integrating proven technologies into solutions that are easy to use, reliable, and scalable.”
- Katie Szyman, CEO of Masimo:
“Expanding our strong, long-standing partnership with Philips allows us to bring Masimo’s best-in-class technologies to more patients and empower clinicians to transform patient care.”
Why It Matters
- Enhanced interoperability: Simplifies workflows and reduces system complexity.
- Smarter decision-making: Delivers timely insights across care settings.
- Scalability: Solutions designed to support both hospitals and home care.
- Aligned strategies: Fits Philips’ broader goal of vendor-neutral interoperability and Masimo’s mission to expand noninvasive monitoring innovation.
About the Companies
- Royal Philips: A global leader in health technology, focused on improving health and well-being through innovation in both consumer and professional healthcare solutions.
- Masimo: A pioneer in advanced noninvasive monitoring technologies, including pulse oximetry, sensors, wearables, and AI-driven solutions.
This renewed alliance combines Philips’ strengths in patient monitoring with Masimo’s cutting-edge sensor and wearable technologies, positioning both companies to drive the next wave of clinically validated, connected care solutions worldwide.
